Einige Inhalte dieser Seite sind nur für Abonnenten sichtbar.       Anmelden     oder      Jetzt abonnieren!

Archiv: Alle Kategorien

Die Saxo Bank publiziert ihre 10 "Outrageous Predictions” für 2018 » Report
ABB achieves breakthrough with world’s most powerful HVDC transformer » Report
Glencore : New Director Appointment » Report
SECO - La situation sur le marché du travail en novembre 2017 » Report
SECO - Die Lage auf dem Arbeitsmarkt im November 2017 » Report
Roche’s Hemlibra every four weeks controlled bleeds in phase III study in haemophilia A » Report
Roche’s Hemlibra every four weeks controlled bleeds in phase III study in haemophilia A
mobilezone: Kontinuität in der Geschäftsführung bei einsAmobile » Report
Novartis tender offer for Advanced Accelerator Applications commences » Report
ARYZTA notes agreement and pricing of Picard offerings » Report
Roche: Phase III IMpower150 study showed Tecentriq (atezolizumab) and Avastin (bevacizumab) plus chemotherapy reduced the risk of disease worsening or death by 38 percent for people with a type of advanced lung cancer » Report
Roche: Phase III IMpower150 study showed Tecentriq (atezolizumab) and Avastin (bevacizumab) plus chemotherapy reduced the risk of disease worsening or death by 38 percent for people with a type of advanced lung cancer
Cassiopea announces completion of recruitment of Phase II proof of concept trial of CB-06-02 trial in genital warts » Report
Kontinuität in der Geschäftsführung bei einsAmobile » Report
Helvetia Venture Fund investiert in InsurTech-Start-up INZMO » Report
Schaffner steigerte im Geschäftsjahr 2016/17 Umsatz und Profitabilität » Report
Novartis Kisqali® is first and only CDK4/6 inhibitor to show superior median PFS compared to oral endocrine therapy as first-line treatment in a prospective, randomized Phase III trial dedicated to... » Report
Eastern Property Holdings Limited (EPH) announces the financing for the upcoming closing of the acquisition of 94% of the property Work Life Center in Hamburg, Germany » Report
Roche Investor Update: FDA grants Roche’s Avastin full approval for most aggressive form of brain cancer » Report
World Gold Council Correction: Gold-backed ETF holdings increased by 9.1t in November* » Report